Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Replacement in Testicular Cancer Survivors (Einstein)
NCT02991209Phase 3Completed
- Start
- Nov 2016
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of AndroForte in Leydig cell hypoplasia (LCH). Started Nov 2016; status: completed.
02
Drugs
AndroForte
03
Conditions
Leydig cell hypoplasia (LCH)
Beyond the preview
Go deeper on NCT02991209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02991209.